Non-functional pancreatic neuroendocrine tumours: ATRX/DAXX and alternative lengthening of telomeres (ALT) are prognostically independent from ARX/PDX1 expression and tumour size - Concepedia

Concepedia

Publication | Open Access

Non-functional pancreatic neuroendocrine tumours: ATRX/DAXX and alternative lengthening of telomeres (ALT) are prognostically independent from ARX/PDX1 expression and tumour size

DOI Full Paper Access

138

Citations

43

References

2021

Year

Wenzel M. Hackeng, Lodewijk A.A. Brosens, Joo Young Kim, Roderick J. O’Sullivan, You-Na Sung, Ta‐Chiang Liu, Dengfeng Cao, Michelle Heayn, Jacqueline A. Brosnan‐Cashman, Soyeon An,

Abstract

ATRX/DAXX and ALT should be considered in the prognostic evaluation of NF-PanNETs including ≤2.0 cm tumours, and are highly specific for pancreatic origin among NET metastases of unknown primary.

References

	Year	Citations

Page 1